Free Trial
TSE:ONC

Oncolytics Biotech (ONC) Stock Price, News & Analysis

Oncolytics Biotech logo
C$1.24 +0.19 (+18.10%)
As of 07/3/2025 03:59 PM Eastern

About Oncolytics Biotech Stock (TSE:ONC)

Key Stats

Today's Range
C$1.03
C$1.24
50-Day Range
C$0.45
C$1.24
52-Week Range
C$0.44
C$2.08
Volume
496,696 shs
Average Volume
126,152 shs
Market Capitalization
C$95.57 million
P/E Ratio
N/A
Dividend Yield
0.31%
Price Target
C$3.50
Consensus Rating
Hold

Company Overview

Oncolytics Biotech Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
19th Percentile Overall Score

ONC MarketRank™: 

Oncolytics Biotech scored higher than 19% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Oncolytics Biotech has received a consensus rating of Hold. The company's average rating score is 2.00, and is based on no buy ratings, 1 hold rating, and no sell ratings.

  • Amount of Analyst Coverage

    Oncolytics Biotech has only been the subject of 1 research reports in the past 90 days.

  • Read more about Oncolytics Biotech's stock forecast and price target.
  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Oncolytics Biotech is -3.45, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Oncolytics Biotech is -3.45, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Book Value per Share Ratio

    Oncolytics Biotech has a P/B Ratio of 10.54. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

  • Short Interest

    There is no current short interest data available for ONC.
  • Dividend Yield

    Oncolytics Biotech has a dividend yield of 0.31%, which is in the bottom 25% of all stocks that pay dividends.

  • Dividend Growth

    Oncolytics Biotech does not have a long track record of dividend growth.

  • Read more about Oncolytics Biotech's dividend.
  • Short Interest

    There is no current short interest data available for ONC.
  • News Sentiment

    Oncolytics Biotech has a news sentiment score of -0.44. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.54 average news sentiment score of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 2 news articles for Oncolytics Biotech this week, compared to 1 article on an average week.
  • Search Interest

    14 people have searched for ONC on MarketBeat in the last 30 days. This is an increase of 250% compared to the previous 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Oncolytics Biotech insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    Only 3.82% of the stock of Oncolytics Biotech is held by insiders.

  • Percentage Held by Institutions

    Only 1.75% of the stock of Oncolytics Biotech is held by institutions.

  • Read more about Oncolytics Biotech's insider trading history.
Receive ONC Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Oncolytics Biotech and its competitors with MarketBeat's FREE daily newsletter.

ONC Stock News Headlines

The Trump Dump is starting; Get out of stocks now?
The first 365 days of the Trump presidency… Will be the best time to get rich in American history.
See More Headlines

ONC Stock Analysis - Frequently Asked Questions

Oncolytics Biotech's stock was trading at C$1.33 on January 1st, 2025. Since then, ONC stock has decreased by 6.8% and is now trading at C$1.24.

Oncolytics Biotech Inc. (TSE:ONC) posted its quarterly earnings results on Tuesday, November, 12th. The company reported ($0.12) earnings per share for the quarter, missing the consensus estimate of ($0.11) by $0.01.

Shares of ONC stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.

Based on aggregate information from My MarketBeat watchlists, some other companies that Oncolytics Biotech investors own include Oncolytics Biotech (ONCY), Ballard Power Systems (BLDP), (ONCYF) (ONCYF), Resverlogix (RVX), Birchcliff Energy (BIR), Enbridge (ENB) and

Company Calendar

Last Earnings
11/12/2024
Today
7/03/2025

Industry, Sector and Symbol

Stock Exchange
TSE
Sector
Medical
Industry
Biotechnology
Sub-Industry
N/A
Current Symbol
TSE:ONC
CIK
N/A
Fax
N/A
Employees
29
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
C$3.50
High Stock Price Target
C$3.50
Low Stock Price Target
C$3.50
Potential Upside/Downside
+184.6%
Consensus Rating
Hold
Rating Score (0-4)
2.00
Research Coverage
1 Analysts

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-C$27.66 million
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A
Cash Flow
C$0.29 per share
Price / Cash Flow
4.22
Book Value
C$0.12 per share
Price / Book
10.46

Miscellaneous

Free Float
N/A
Market Cap
C$94.80 million
Optionable
Not Optionable
Beta
1.35
10 "Recession Proof" Stocks That Will Thrive in Any Market Cover

Which stocks are likely to thrive in today's challenging market? Enter your email address and we'll send you MarketBeat's list of ten stocks that will drive in any economic environment.

Get This Free Report

This page (TSE:ONC) was last updated on 7/4/2025 by MarketBeat.com Staff
From Our Partners